Financial results - KOMTUR PHARMACEUTICALS SRL

Financial Summary - Komtur Pharmaceuticals Srl
Unique identification code: 38459656
Registration number: J23/5594/2017
Nace: 7311
Sales - Ron
4.089.417
Net Profit - Ron
312.301
Employees
6
Open Account
Company Komtur Pharmaceuticals Srl with Fiscal Code 38459656 recorded a turnover of 2024 of 4.089.417, with a net profit of 312.301 and having an average number of employees of 6. The company operates in the field of Activităţi ale agenţiilor de publicitate having the NACE code 7311.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Komtur Pharmaceuticals Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - 0 0 2.161 29.804 173.612 587.295 2.290.065 4.089.417
Total Income - EUR - - 0 1 2.171 30.098 174.110 592.195 2.289.150 4.090.069
Total Expenses - EUR - - 574 30.319 59.023 73.074 130.701 393.808 2.068.176 3.729.066
Gross Profit/Loss - EUR - - -574 -30.318 -56.852 -42.976 43.409 198.388 220.974 361.002
Net Profit/Loss - EUR - - -574 -30.318 -56.874 -43.265 41.975 193.589 192.130 312.301
Employees - - 0 1 2 1 2 4 5 6
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 79.6%, from 2.290.065 euro in the year 2023, to 4.089.417 euro in 2024. The Net Profit increased by 121.245 euro, from 192.130 euro in 2023, to 312.301 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Komtur Pharmaceuticals Srl

Rating financiar

Financial Rating -
KOMTUR PHARMACEUTICALS SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Komtur Pharmaceuticals Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Komtur Pharmaceuticals Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Komtur Pharmaceuticals Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Komtur Pharmaceuticals Srl - CUI 38459656

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - 0 32 9 9 1.057 1.579 7.236 150.497
Current Assets - - 24.793 50.682 49.984 62.976 173.682 242.644 1.481.893 2.685.862
Inventories - - 0 647 36.181 35.318 34.534 436 34.070 374.861
Receivables - - 0 1.149 3.299 21.690 33.581 204.748 1.230.061 2.163.588
Cash - - 24.793 48.886 10.504 5.968 105.566 37.460 217.762 147.413
Shareholders Funds - - 24.382 -6.384 -63.134 -105.202 -60.894 132.506 324.234 634.723
Social Capital - - 24.956 24.498 24.023 23.568 23.045 23.117 23.047 22.918
Debts - - 411 57.098 113.127 168.186 235.633 111.968 1.165.518 2.203.773
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7311 - 7311"
CAEN Financial Year 7311
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 2.685.862 euro in 2024 which includes Inventories of 374.861 euro, Receivables of 2.163.588 euro and cash availability of 147.413 euro.
The company's Equity was valued at 634.723 euro, while total Liabilities amounted to 2.203.773 euro. Equity increased by 312.301 euro, from 324.234 euro in 2023, to 634.723 in 2024.

Risk Reports Prices

Reviews - Komtur Pharmaceuticals Srl

Comments - Komtur Pharmaceuticals Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.